Rare diseases
Investigational molecules
Locations
346 conditions with trials, the busiest first
960 trials across Europe, recruiting first
Study on Apalutamide and Drug Combination for Patients with Metastatic Castration-Sensitive Prostate Cancer
FranceStudy on the Safety and Effectiveness of CRN04894 for Patients with Congenital Adrenal Hyperplasia
GermanyStudy on the Effectiveness of Biomarker Staging Compared to Conventional Staging in Women with Early-Stage Endometrial Cancer Using Paclitaxel and Carboplatin
SwedenStudy on Preoperative Treatment for HER2 Positive Breast Cancer Using Docetaxel, Pertuzumab, and Trastuzumab in Patients with Primary Breast Cancer
SwedenStudy of Apalutamide and Androgen Deprivation Therapy for Patients with High-Risk Prostate Cancer
CzechiaStudy on the Effectiveness and Safety of MC2-25 Cream for Women with Vulvar Lichen Sclerosus
DenmarkStudy on the Effectiveness and Safety of Apalutamide and GnRH Agonist in Patients with High-Risk Prostate Cancer Undergoing Radiation Therapy
BelgiumStudy of Pembrolizumab and Lenvatinib for Patients with Advanced or Recurrent Endometrial Cancer
AustriaStudy of Patritumab Deruxtecan for Patients with Brain Metastases from Advanced Breast or Lung Cancer and Leptomeningeal Disease from Solid Tumors
AustriaStudy on Infertility: Comparing Corifollitropin Alfa and Follitropin Beta for Women Undergoing Elective Fertility Preservation
SpainStudy on the Effects and Safety of PLX038 for Patients with Advanced or Metastatic Triple-Negative Breast Cancer
FranceStudy on Pembrolizumab, Lenvatinib, and Belzutifan for Patients with Liver, Colon, Pancreatic, Bile Duct, Gallbladder, Endometrial, or Esophageal Cancer
BelgiumThe therapies tested most often in Reproductive system and breast disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
